| ZenaTech’s ZenaDrone Interceptor P-1, Single-Use Autonomous Interceptor Drone, Targeted to Sell for Under $5,000 USD |
Globe Newswire |
03/19 |
08:00 |
| LiveOne (Nasdaq: LVO) Announces B2B Partnership with Samsung TV; Expands Reach to 100M+ Smart TVs |
Globe Newswire |
03/19 |
08:00 |
| Rezolve Ai to Showcase Production-Ready Agentic Commerce Platform at Shoptalk 2026 |
Globe Newswire |
03/19 |
08:00 |
| Strive, Inc. Announces Financial Results |
Globe Newswire |
03/19 |
08:00 |
| Doctolib selects Diginex Limited’s Plan A to turn their carbon management into strategic business value |
Globe Newswire |
03/19 |
08:00 |
| Meltwater Named to G2’s 2026 Best Software Awards |
Globe Newswire |
03/19 |
08:00 |
| Aduro Signs MOU to Develop a Commercial Licence Package for Hydrochemolytic™ Technology |
Globe Newswire |
03/19 |
08:00 |
| Picard Medical / SynCardia Highlight Second Successful Total Artificial Heart Bridge to Transplant at UCSF Health |
Globe Newswire |
03/19 |
08:00 |
| Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update |
Globe Newswire |
03/19 |
08:00 |
| INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease |
Globe Newswire |
03/19 |
08:00 |
| EagleNXT eBee VISION ISR Drone Selected by U.S. Army for advanced training |
Globe Newswire |
03/19 |
08:00 |
| NevGold Intercepts 11.42 g/t AuEq Over 7.7 Meters (2.64% Antimony And 1.17 g/t Au) Within 4.91 g/t AuEq Over 27.4 Meters (1.09% Antimony And 0.67 g/t Au); Initial Antimony-Gold Mineral Resource Estimate On Schedule For Q2-2026 With Focus On Near-Term Antimony Production |
Globe Newswire |
03/19 |
07:45 |
| Volatus Aerospace Announces Graduation to Toronto Stock Exchange; Trading to Commence March 20, 2026 |
Globe Newswire |
03/19 |
07:45 |
| Intuitive Machines Reports Fourth Quarter and Full-Year 2025 Financial Results |
Globe Newswire |
03/19 |
07:30 |
| NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial |
Globe Newswire |
03/19 |
07:30 |
| TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million |
Globe Newswire |
03/19 |
07:30 |
| Mount Logan Capital Inc. Announces Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/19 |
07:30 |
| CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology |
Globe Newswire |
03/19 |
07:30 |
| InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones |
Globe Newswire |
03/19 |
07:30 |
| BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health |
Globe Newswire |
03/19 |
07:30 |
| Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting |
Globe Newswire |
03/19 |
07:30 |
| Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical |
Globe Newswire |
03/19 |
07:30 |
| Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study |
Globe Newswire |
03/19 |
07:30 |
| AlphaTON Capital Acquires Controlling Interest in GAMEE, Adding 119 Million Users to its Telegram Ecosystem Portfolio |
Globe Newswire |
03/19 |
07:30 |
| Mount Logan–Managed Opportunistic Credit Interval Fund (SOFIX) to Acquire $100+ Million of Assets from Yieldstreet Alternative Income Fund (YS AIF) |
Globe Newswire |
03/19 |
07:29 |
